Health Observer Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Bermuda.

Press releases published on April 20, 2026

Apr. 20, 2026

ONWARD Medical Publishes Closing of Bookbuild Offering

Indeterminate GlobeNewswire

Apr. 20, 2026

Naomi Ruth Cohen Institute For Mental Health Education to Host Annual Conference Addressing the Growing Crisis of Loneliness

Indeterminate GlobeNewswire

Apr. 20, 2026

Global Vascular Access Device Market to Reach USD 8.68 Billion by 2031 | MarketsandMarkets™

Indeterminate GlobeNewswire

Apr. 20, 2026

AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses

Indeterminate GlobeNewswire

Apr. 20, 2026

Baba Appoints Former Mount Sinai Executive Director to Lead Clinical Operations

Indeterminate GlobeNewswire

Apr. 20, 2026

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform

Indeterminate GlobeNewswire

Apr. 20, 2026

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

Indeterminate GlobeNewswire

Apr. 20, 2026

HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.

Indeterminate GlobeNewswire

Apr. 20, 2026

AVIS À IGNORER -- BVI Medical, Inc.

Indeterminate GlobeNewswire

Apr. 20, 2026

$3.2+ BN Medical Radiation Shielding Market Forecasts to 2034: Rising More Imaging and Therapy Procedures Due to Growing Chronic Diseases and Increasing Risk Awareness

Indeterminate GlobeNewswire

Apr. 20, 2026

Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc.

Indeterminate GlobeNewswire

Apr. 20, 2026

First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

Indeterminate GlobeNewswire

Apr. 20, 2026

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

Indeterminate GlobeNewswire

Apr. 20, 2026

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

Indeterminate GlobeNewswire

Apr. 20, 2026

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

Indeterminate GlobeNewswire

Apr. 20, 2026

Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa

Indeterminate GlobeNewswire

Apr. 20, 2026

Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

Indeterminate GlobeNewswire

Apr. 20, 2026

Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Indeterminate GlobeNewswire